Background:

The convergence of Ginkgo biloba and soy isoflavones represents a novel paradigm in nutritional pharmacology, where two mechanistically distinct agents co-regulate the Neuro–Endocrine–Vascular–Metabolic (NEVM) system.

This study proposes and substantiates a four-axis integrative framework in which Ginkgo biloba acts as the executive synchronizer - modulating energy metabolism, endothelial dynamics, and neurotransmitter balance - while soy isoflavones function as the regulatory initiator, recalibrating endocrine rhythm through selective estrogen receptor-β (ER-β) and G-protein–coupled estrogen receptor (GPER1) signaling.

Methods and Framework:

Through a synthesis of mechanistic literature, clinical trial data, and translational analyses, this paper integrates evidence from three key pathological contexts: menopausal syndrome, premenstrual dysphoric and metabolic-affective disorders (PMS/PMDD), and neuro-metabolic dysregulation.

Each condition was deconstructed into its primary axis imbalance - hormonal, neurochemical, vascular, or energetic - and then reconstructed through Ginkgo–Isoflavone–cofactor synergy (Vitex agnus-castus, magnesium, selenium, and vitamin E), forming a dynamic multi-nutrient network of systemic restoration.

Results and Mechanistic Insight:

Across all models, Ginkgo biloba activated AMPK–PGC-1α–Nrf2 and PI3K–AKT–eNOS pathways, enhancing mitochondrial biogenesis, nitric oxide bioavailability, and cerebral perfusion.

Soy isoflavones restored ER-β–mediated genomic signaling, improving serotonin synthesis (TPH2 upregulation), mitochondrial transcriptional control, and vascular remodeling.

The combined effect re-established bioenergetic and neurochemical coherence, converting endocrine modulation into vascular and cognitive stability.

Supporting cofactors extended these effects: magnesium reinforced AMPK–GABA coupling; selenium and vitamin E stabilized endothelial redox defense; Vitex agnus-castus normalized dopaminergic feedback.

Conclusions:

The findings establish a coherent systems framework in which nutrient synergy acts as network synchronization, not nutrient substitution.

The Ginkgo biloba–Isoflavone axis, supported by specific micronutrient partners, redefines complex chronic conditions such as menopausal transition, PMS/PMDD, and metabolic cognitive fatigue as disorders of system desynchronization, treatable through multi-axis coherence therapy.

This work positions Ginkgo biloba as the central synchronizer and soy isoflavones as the endocrine catalyst of the NEVM system - together forming a biological model of cross-axis harmony within the Keyora nutritional pharmacology paradigm.